BAL5788

Known as: RO 65-5788, BAL 5788, JNJ30982081 
 

Topic mentions per year

Topic mentions per year

2002-2016
024620022016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
INTRODUCTION With resistance of S. aureus, the most prevalent identified pathogen in skin and soft tissue infections, on the rise… (More)
Is this relevant?
2008
2008
Multidrug-resistant strains of Staphylococcus aureus continue to increase in frequency worldwide, both in hospitals and in the… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2006
2006
Ceftobiprole (BAL9141) is an investigational cephalosporin active against methicillin- and vancomycin-resistant staphylococci… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Ceftobiprole (formerly BAL9141), the active component of the prodrug BAL5788 (ceftobiprole medocaril), is a novel cephalosporin… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2004
2004
BAL5788 is a water-soluble prodrug of BAL9141, a new broad-spectrum cephalosporin with high levels of in vitro activity against… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
2004
2004
BAL5788 is the water-soluble prodrug of BAL9141, a novel broad-spectrum cephalosporin with potent bactericidal activities against… (More)
Is this relevant?
2004
2004
BAL5788 is the water-soluble prodrug of BAL9141, a novel broad-spectrum cephalosporin with potent bactericidal activity against… (More)
Is this relevant?
2004
2004
BAL9141, the active principle of prodrug BAL5788, is a parenteral cephalosporin active against oxacillin-resistant Staphylococcus… (More)
Is this relevant?
2004
2004
BAL9141, a new antimicrobial agent belonging to the class of parenteral pyrrolidinone-3-ylidenemethyl cephalosporins, is active… (More)
Is this relevant?
2002
2002
The therapeutic efficacy of BAL9141 (formerly Ro 63-9141), a novel cephalosporin with broad in vitro activity that also has… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?